DAC/ADC Characterization Scientist II

Nurix Therapeutics

Brisbane (CA)

On-site

USD 140,000 - 161,000

Full time

14 days+
Application generator

A complete application in a minute — tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Nurix Therapeutics is seeking a seasoned biochemist/analytical chemist to lead the DAC screening characterization platform. You will design and execute high-throughput assays, drive DAR isomer and glycosylation analyses, and integrate data to guide conjugate advancement.

Work spans early screening through candidate selection with cross-functional teams. The role requires hands-on method development and strong communication to biology, chemistry, and platform groups, with a strategic impact on

Qualifications

  • BS/BA with 12+ years, MS/MA with 8+ years, or PhD with 4+ years in biochemistry/analytical chemistry
  • Expertise in ADC/DAC & antibody characterization from method development to data interpretation
  • Experience with LCMS & HPLC methods for antibody/conjugate analysis including DAR, SEC, peptide mapping

Responsibilities

  • Design, execute and own the DAC screening characterization platform including DAR, aggregation, protein quantitation, and QC thresholds.
  • Lead and conduct in-depth characterization of antibodies and advanced DACs including isomers, glycosylation, peptide mapping, and stability.
  • Integrate DAR, purity, hydrophobicity, and stability data into unified assessments with QC cutoffs for go/no-go decisions.
  • Develop, optimize, and troubleshoot LCMS and HPLC methods for throughput and robustness; establish plate-based sample prep workflows.
  • Present findings to project teams and collaborate with chemistry, bioanalytical, and cell screening groups.

Skills

Experiment design
Data interpretation
Cross-functional communication
Prioritization

Education

BS/BA 12+ yrs
MS/MA 8+ yrs
PhD 4+ yrs

Tools

LCMS
HPLC
DAR analysis
SEC
HIC

Job description

Nurix Therapeutics is seeking a seasoned biochemist/analytical chemist to lead the DAC screening characterization platform. You will design and execute high-throughput assays, drive DAR isomer and glycosylation analyses, and integrate data to guide conjugate advancement.

Work spans early screening through candidate selection with cross-functional teams. The role requires hands-on method development and strong communication to biology, chemistry, and platform groups, with a strategic impact on

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

DAC & Antibody Conjugate Characterization Scientist II
DAC & Antibody Conjugate Characterization Scientist II

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 140,000 - 161,000
ADC/DAC Characterization Scientist II - Antibody Conjugates
ADC/DAC Characterization Scientist II - Antibody Conjugates

BioSpace • Brisbane (CA)

On-site
USD 140,000 - 161,000
Analytical Scientist, DAC/ADC Characterization
Analytical Scientist, DAC/ADC Characterization

Nurix, Inc. • California (MO)

On-site
USD 140,000 - 161,000
Bioanalytical Scientist, DACs & LC-MS/MS PK/PD
Bioanalytical Scientist, DACs & LC-MS/MS PK/PD

Nurix Therapeutics • Brisbane (CA)

On-site
USD 90,000 - 130,000
Scientist II, Degrader Antibody Conjugate Characterization
Scientist II, Degrader Antibody Conjugate Characterization

Nurix Therapeutics • Brisbane (CA)

On-site
USD 140,000 - 161,000
Senior Scientist, DAC Bioanalysis & LC-MS/MS
Senior Scientist, DAC Bioanalysis & LC-MS/MS

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 130,000 - 180,000
Scientist II, Degrader Antibody Conjugate Characterization
Scientist II, Degrader Antibody Conjugate Characterization

BioSpace • Brisbane (CA)

On-site
USD 140,000 - 161,000
Lead Scientist, DAC Bioanalysis & LC-MS/MS
Lead Scientist, DAC Bioanalysis & LC-MS/MS

BioSpace • Brisbane (CA)

On-site
USD 120,000 - 180,000
Cellular Pharmacology Scientist, DAC Screening & Assays
Cellular Pharmacology Scientist, DAC Screening & Assays

Nurix Therapeutics • Brisbane (CA)

On-site
USD 127,000 - 143,000
Scientist II, Degrader Antibody Conjugate Characterization
Scientist II, Degrader Antibody Conjugate Characterization

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 140,000 - 161,000